4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-21-001279
Director acquired 95,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hayden Michael R · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-29 | Exercise or conversion : show line 1 in the form | +50,000 | $5.44 | $272,000 | 50,000 | D |
| 2021-01-29 | Exercise or conversion : show line 2 in the form | +30,000 | $6.06 | $181,800 | 80,000 | D |
| 2021-01-29 | Exercise or conversion : show line 3 in the form | +15,000 | $6.42 | $96,300 | 95,000 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-01-29 | Exercise or conversion : show line 4 in the form Stock Option (right to buy) | −50,000 | 0 | D |
| 2021-01-29 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −30,000 | 0 | D |
| 2021-01-29 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −15,000 | 0 | D |
Loading xslF345X03/wf-form4_161229708841560.xml…